Earnings History Data for Terns Pharmaceuticals (TERN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Terns Pharmaceuticals

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-03-2024	AH		TERN	Terns Pharmaceuticals	441.00	-0.29	-0.29	0.00	Terns Pharmaceuticals GAAP EPS of -$0.29 [3/14/2024 5:48 PM]	7.18	0.47 (7.00%)	6.99	0.28 (4.17%)	3.26 - 14.04	514,764	1,600,000	2,531
Terns Pharmaceuticals GAAP EPS of -$0.29 [3/14/2024 5:48 PM] Terns to report Phase 1 data on GLP-1 drug in 2H 2024 [3/14/2024 7:23 PM]
14-11-2023	PM		TERN	Terns Pharmaceuticals	215.00	-0.42	-0.31	0.00	Terns Pharmaceuticals GAAP EPS of -$0.42 misses by $0.12 [11/14/2023 2:44 PM]	3.54	0.17 (5.04%)	0.0	0.0 (0.00%)	3.26 - 14.04	442,693	420,000	0
Terns Pharmaceuticals GAAP EPS of -$0.42 misses by $0.12 [11/14/2023 2:44 PM]
08-08-2023	AH		TERN	Terns Pharmaceuticals	381.00	-0.25	-0.32	0.00	Terns Pharmaceuticals GAAP EPS of -$0.25 beats by $0.08 [8/8/2023 5:55 PM]	6.03	-0.96 (-13.81%)	7.00	0.01 (0.14%)	1.97 - 14.04	2,019,754	620,000	61,379
Terns Pharmaceuticals GAAP EPS of -$0.25 beats by $0.08 [8/8/2023 5:55 PM] Terns slips after mid-stage readout for NASH candidate [8/9/2023 1:55 PM]
27-03-2023	AH	4:05 PM ET (Mar 27)	TERN	Terns Pharmaceuticals	342.00	-0.29	-0.42	0.00	Terns Pharmaceuticals GAAP EPS of -$0.29 [3/27/2023 5:16 PM]	10.56	1.12 (11.86%)	9.44	0.0 (0.00%)	1.45 - 11.44	1,371,917	280,000	505
Terns Pharmaceuticals appoints Kuriakose as CMO of Terns oncology [3/27/2023 8:19 AM] Terns Pharmaceuticals GAAP EPS of -$0.29 [3/27/2023 5:16 PM]
09-11-2022	AH	4:05 PM ET (Nov 9)	TERN	Terns Pharmaceuticals	172.00	-0.44	-0.51	0.00	Terns Pharmaceuticals GAAP EPS of -$0.44 beats by $0.07 [11/9/2022 5:19 PM]	4.89	-0.90 (-15.54%)	5.68	-0.11 (-1.90%)	1.45 - 9.60	145,001	80,000	692
Terns Pharmaceuticals GAAP EPS of -$0.44 beats by $0.07 [11/9/2022 5:19 PM]
08-08-2022	AH	4:05 PM ET (Aug 8)	TERN	Terns Pharmaceuticals	54.00	-0.55	-0.63	0.00	Terns Pharmaceuticals GAAP EPS of -$0.55 beats by $0.08 [8/8/2022 5:25 PM]	2.09	-0.01 (-0.48%)	0.0	0.0 (0.00%)	1.45 - 13.77	58,160	70,000	0
Terns Pharmaceuticals GAAP EPS of -$0.55 beats by $0.08 [8/8/2022 5:25 PM]
16-05-2022	AH	4:05 PM ET (May 16)	TERN	Terns Pharmaceuticals	39.00	-0.55	-0.67	0.00	Terns Pharmaceuticals GAAP EPS of -$0.55 [5/16/2022 4:50 PM]	1.57	0.07 (4.67%)	1.50	0.0 (0.00%)	1.47 - 19.97	120,728	80,000	1,014
Terns Pharmaceuticals GAAP EPS of -$0.55 [5/16/2022 4:50 PM] Terns Pharmaceuticals Reports First Quarter 2022 Financial Results and Business Updates [May-16-22 04:05PM]
03-03-2022	AH		TERN	Terns Pharmaceuticals	87.00	-0.56	-0.67	0.00	Terns Pharmaceuticals GAAP EPS of -$0.56 [3/3/2022 5:42 PM]	3.21	0.09 (2.88%)	3.12	0.0 (0.00%)	3.04 - 28.36	11,703	70,000	399
Terns Pharmaceuticals GAAP EPS of -$0.56 [3/3/2022 5:42 PM] Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights [Mar-03-22 04:05PM]
16-08-2021	AH		TERN	Terns Pharmaceuticals, Inc.	261.00	-0.43	-0.81	0.00	Terns Pharmaceuticals EPS beats by $0.37 [8/16/2021 4:29 PM]	11.20	1.58 (16.42%)	0.0	0.0 (0.00%)	6.92 - 28.36	166,242	80,000	0
Terns Pharmaceuticals EPS beats by $0.37 [8/16/2021 4:29 PM] Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights [Aug-16-21 04:05PM]
13-05-2021	AH	4:05 PM ET (May 13)	TERN	Terns Pharmaceuticals, Inc.	386.00	-0.88	-0.53	0.00	Terns Pharmaceuticals EPS misses by $0.35 [5/13/2021 5:29 PM]	16.01	0.85 (5.61%)	15.16	0.0 (0.00%)	14.58 - 28.36	22,210	50,000	253
Terns Pharmaceuticals EPS misses by $0.35 [5/13/2021 5:29 PM] Terns Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-13-21 04:05PM]